Publications

2018

Schneider U, Walsh L, Newhauser W. Tumour size can have an impact on the outcomes of epidemiological studies on second cancers after radiotherapy. Radiat  Environ Biophys. 2018 Nov;57(4):311-319. doi: 10.1007/s00411-018-0753-6. Epub 2018 Aug 31.

Hauri P, Schneider U. Whole-body dose and energy measurements in radiotherapy by a combination of LiF:Mg,Cu,P and LiF:Mg,Ti. Z Med Phys. 2018 Apr;28(2):96-109.

Rohrer Bley C, Meier V, Schneider U. Dosimetric benefit of adaptive radiotherapy in the neoadjuvant management of canine and feline thymoma-An exploratory case series. Vet Comp Oncol. 2018 Jan 8. doi: 10.1111/vco.12382.

Schneider U, Vasi F, Schmidli K. Besserer J. Track event theory: A cell survival and RBE model consistent with nanodosimetry. Radiation Protection Dosimetry, 11 December 2018.

2017

Schneider U, Vasi F, Besserer J. The probabilities of one- and multi-track events for modeling radiation-induced cell kill. Radiat Environ Biophys. 2017 May 19. doi: 10.1007/s00411-017-0697-2.

Hauri P, Hälg RA, Schneider U. Technical Note: Comparison of peripheral patient dose from MR-guided (60) Co therapy and 6MV linear accelerator IGRT. Med  Phys. 2017 Apr 24. doi: 10.1002/mp.12293.

Schneider CW, Newhauser WD, Wilson LJ, Schneider U, Kaderka R, Miljanić S, Knežević Ž, Stolarcyzk L, Durante M, Harrison RM. A descriptive and broadly applicable model of therapeutic and stray absorbed dose from 6 MV to 25 MV photon beams. Med Phys. 2017 Apr 21. doi: 10.1002/mp.12286.

Stokkevåg CH, Schneider U, Muren LP, Newhauser W. Radiation-induced cancer risk predictions in proton and heavy ion radiotherapy. Phys Med. 2017 May 13. pii: S1120-1797(17)30109-6. doi: 10.1016/j.ejmp.2017.04.022.

Ernst M, Manser P, Dula K, Volken W, Stampanoni MF, Fix MK. TLD measurements and Monte Carlo calculations of head and neck organ and effective doses for cone beam computed tomography using 3D Accuitomo 170. Dentomaxillofac Radiol. 2017Oct;46(7):20170047. doi: 10.1259/dmfr.20170047.

Hauri P, Hälg RA, Schneider U. Technical Note: Comparison of peripheral patient dose from MR-guided (60) Co therapy and 6MV linear accelerator IGRT. Med  Phys. 2017 Apr 24. doi: 10.1002/mp.12293.

Schneider U, Walsh L. Risk of secondary cancers: Bridging epidemiology and modeling. Phys Med. 2017 Mar 28. pii: S1120-1797(17)30066-2. doi:10.1016/j.ejmp.2017.03.011.

Schneider U, Ernst M, Hartmann M. The dose-response relationship for cardiovascular disease is not necessarily linear. Radiat Oncol. 2017 Apr 27;12(1):74. doi: 10.1186/s13014-017-0811-2.

Schneider CW, Newhauser WD, Wilson LJ, Schneider U, Kaderka R, Miljanić S, Knežević Ž, Stolarcyzk L, Durante M, Harrison RM. A descriptive and broadly applicable model of therapeutic and stray absorbed dose from 6 MV to 25 MV photon beams. Med Phys. 2017 Apr 21. doi: 10.1002/mp.12286.

Ghadjar P, Hayoz S, Zwahlen DR, Thalmann GN, Aebersold DM; Swiss Group for Clinical Cancer Research (SAKK).. Is Dose-Intensified Salvage Radiation Therapy After Prostatectomy Beneficial? J Clin Oncol. 2017 May 1;35(13):1490-1491. doi: 10.1200/JCO.2016.70.7265.

2016

Zwahlen DR, Bischoff LI, Gruber G, Sumila M, Schneider U. Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes. Radiat Oncol. 2016 Nov 10;11(1):149.

Schneider U, Vasi F, Besserer J. The Impact of the Geometrical Structure of the DNA on Parameters of the Track-Event Theory for Radiation Induced Cell Kill.  PLoS One. 2016 Oct 19;11(10):e0164929. doi: 10.1371/journal.pone.0164929.

Hauri P, Hälg RA, Besserer J, Schneider U. A general model for stray dose calculation of static and intensity-modulated photon radiation. Med Phys. 2016 Apr;43(4):1955. doi: 10.1118/1.4944421.

Schneider U, Hälg RA, Baiocco G, Lomax T. Neutrons in proton pencil beam scanning: parameterization of energy, quality factors and RBE. Phys Med Biol. 2016 Aug 3;61(16):6231-6242.

Schneider U, Hälg RA, Lomax T. Neutrons in active proton therapy: Parameterization of dose and dose equivalent. Z. Med. Phys. (2016) http://dx.doi.org/10.1016/j.zemedi.2016.07.001

Walsh L, Schneider U. The influence of follow-up on DS02 low-dose ranges with a significant excess relative risk of all solid cancer in the Japanese A-bomb survivors. Radiat Environ Biophys. 2016 Sep 1.

Rohrer Bley C, Meier V, Schwarz P, Roos M, Besserer J. A complication probability planning study to predict the safety of a new protocol for intracranial tumour radiotherapy in dogs. Vet Comp Oncol. 2016 Aug 31. doi: 10.1111/vco.12265.

Ghadjar P, Hayoz S, Genitsch V, Zwahlen DR, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller AC, Putora PM, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi NC, Reuter C, Bodis S, Khanfir K, Budach V, Aebersold DM, Thalmann GN; Swiss Group for Clinical Cancer Research (SAKK).. Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate
cancer. BJU Int. 2016 Dec 17. doi: 10.1111/bju.13742.

2015

Schneider U and Hälg R. The impact of neutrons in clinical proton therapy. Front. Oncol. 2015, 5:235. doi:10.3389/fonc.2015.00235

Schneider  U, Hälg  R, Besserer  J. Concept for quantifying the dose from image guided radiotherapy. Radiation Oncology.2015, 10:188

Schneider U, Walsh L. Age at exposure and attained age variations of cancer risk in the Japanese A-bomb and radiotherapy cohorts. Med Phys. 2015 Aug;42(8):4755.

Besserer J, Schneider U. A track-event theory of cell survival. Z Med Phys.
2015 Jun;25(2):168-75.

Besserer J, Schneider U. Track-event theory of cell survival with second-order repair. Radiat Environ Biophys. 2015 May;54(2):167-74.

Beckmann K, Carrera I, Steffen F, Golini L, Kircher PR, Schneider U, Bley C. A newly designed radiation therapy protocol in combination with prednisolone as treatment for meningoencephalitis of unknown origin in dogs: a prospective pilot study introducing magnetic resonance spectroscopy as monitor tool. Acta Vet Scand. 2015 Jan 31;57(1):4.

2014

Schneider U, Sumila M, Robotka J, Weber D, Gruber G. Radiation-induced second malignancies after involved-node radiotherapy with deep-inspiration breath-hold technique for early stage Hodgkin Lymphoma: a dosimetric study. Radiat Oncol. 2014 Feb 18;9(1):58.

Hälg RA, Besserer J, Boschung M, Mayer S, Lomax AJ, Schneider U. Measurements of the neutron dose equivalent for various radiation qualities, treatment machines and delivery techniques in radiation therapy. Phys Med Biol. 2014 May 21;59(10):2457-68.

Schneider U, Hälg RA, Hartmann M, Mack A, Storelli F, Joosten A, Möckli R, Besserer J. Accuracy of out-of-Field Dose Calculation of Tomotherapy and Cyberknife Treatment Planning Systems: A Dosimetric Study. Z Med Phys. 2014 Sep;24(3):211-5.

Sumila M, Mack A, Schneider U, Storelli F, Curschmann J, Gruber G. Long-term intra-fractional motion of the prostate using hydrogel spacer during Cyberknife® treatment for prostate cancer--a case report. Radiat Oncol. 2014 Aug 20;9:186.

2013

Cella L, Conson M, Pressello MC, Molinelli S, Schneider U, Donato V, Orecchia R, Salvatore M, Pacelli R. Hodgkin‘s lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms.Radiation Oncology 2013, 8:22.

Walsh L, Schneider U. A method for determining weights for excess relative risk and excess absolute risk when applied in the calculation of lifetime risk of cancer from radiation exposure. Radiat Environ Biophys. 2013 Mar;52(1):135-45.

Fuji H, Schneider U, Ishida Y, Konno M, Yamashita H, Kase Y, Murayama S, Onoe  T, Ogawa H, Harada H, Asakura H, Nishimura T. Assessment of organ dose reduction  and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas. Radiat Oncol. 2013 Nov 1;8(1):255.

Fischbach M, Hälg RA, Hartmann M, Besserer J, Gruber G, Schneider U. Measurement of skin and target dose in post-mastectomy radiotherapy using 4 and 6 MV photon beams. Radiat Oncol. 2013 Nov 16;8(1):270.

2012

Hälg, R, Besserer J, Schneider U. Systematic measurements of whole-body imaging dose distributions in image-guided radiation therapy. Med Phys. 2012 39(12):7650-7661.

Hälg, R, Besserer J, Schneider U. Systematic measurements of whole-body dose distributions for various treatment machines and delivery techniques in radiation therapy. Med Phys. 2012 39(12):7662-7676.

Walsh L, Schneider U. A method for determining weights for excess relative risk and excess absolute risk in calculations of lifetime risk of cancer from radiation exposure. Radiat Environ Biophys. 2013 Mar;52(1):135-45.

Schneider U, Schäfer B. Model of accelerated carcinogenesis based on proliferative stress and inflammation for doses relevant to radiotherapy. Radiat. Environ. Biophys. 2012 51:451–456.

Hälg, R, Besserer J, Boschung M, Mayer S, Clasie B, Kry S, Schneider U. Field calibration of PADC track etch detectors for local neutron dosimetry in man using different radiation qualities. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 2012 694:205-210.

Paganetti H, Athar BS, Moteabbed M, A Adams J, Schneider U, Yock TI. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field. Phys Med Biol. 2012 Oct 7;57(19):6047-61.

Hälg, R, Besserer J, Boschung M, Mayer S, Schneider U. Monitor units are not predictive of neutron dose for high-energy IMRT. Radiation Oncology 2012 7:138.

Schneider U, Besserer J, Hartmann M. Technical Note: Spatial resolution of proton tomography: Impact of air gap between patient and detector. Med Phys. 2012 Feb;39(2):798.

2011

Schneider U. Modeling the Risk of Secondary Malignancies after Radiotherapy. Genes 2011, 2, 1033-1049.

Bartkowiak D, Humble N, Suhr P, Hagg J, Mair K, Polivka B, Schneider U, Bottke D, Wiegel T. Second cancer after radiotherapy, 1981-2007. Radiother Oncol. 2012 Oct;105(1):122-6.

Schneider U, Sumila M, Robotka J. Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Theor Biol Med Model. 2011 Jul 26;8:27.

Schneider U, Pedroni E, Hartmann M, Besserer J, Lomax T. Spatial resolution of proton tomography: methods, initial phase space and object thickness. Z Med Phys. 2012 Jun;22(2):100-8.

Schneider U, Sumila M, Robotka J, Gruber G, Mack A, Besserer J. Dose-response relationship for breast cancer induction at radiotherapy dose. Radiat Oncol. 2011 Jun 8;6:67.

Hälg RA, Besserer J, Schneider U. Comparative simulations of neutron dose in soft tissue and phantom materials for proton and carbon ion therapy with actively scanned beams. Med Phys. 2011 Jun;38(6):3149-56.

2010

Schneider U, Stipper A., Besserer J. Dose-response relationship for lung cancer induction at radiotherapy dose. Z Med Phys. 2010;20:206-214.

Schneider U, Besserer J, Mack A. Hypofractionated radiotherapy has the potential for second cancer reduction. Theor Biol Med Model. 2010 Feb 11;7(1):4.

2009

Pfaffenberger A, Schneider U, Poppe B, Oelfke U. Phenomenological modelling of second cancer incidence for radiation treatment planning. Z Med Phys. 2009;19(4):236-50.

Mayer-Stankeová S, Fidel J, Wergin MC, Hauser B, Sumová A, Goitein G, Pedroni E, Lomax AJ, Schneider U, Blattmann H, Kaser-Hotz B. Proton spot scanning radiotherapy of spontaneous canine tumors. Vet Radiol Ultrasound. 2009 May-Jun;50(3):314-8.

Schneider U. Mechanistic model of radiation induced cancer after fractionated radiotherapy using the linear-quadratic formula. Med Phys. 2009, 36(4):1138-1143.

Zwahlen DR, Ruben JD, Jones P, Gagliardi F, Millar JL, Schneider U. Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):539-45.

Schneider U, Walsh L. Cancer risk above 1 Gy and the impact for space radiation protection. Advances in Space Research 44 (2009) 202–209.

2008

Schneider U, Lomax A, Timmermann B. Second cancers in children treated with modern radiotherapy techniques. Radiother Oncol. 2008 Nov;89(2):135-40.

Schneider U, Walsh L. Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Radiat Environ Biophys. 2008 Apr;47(2):253-63.

Oertel S, Schneider U, Keel M, Lütolf UM, Bosshard G. Prophylaxis of Heterotopic Ossification in Patients Sedated after Polytrauma: Medical and Ethical Considerations. Strahlenther Onkol. 2008, 184(4):212-217.

Zwahlen DR, Martin JM, Millar JL, Schneider U. Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma. Int J Radiat Oncol Biol Phys. 2008, 70(3):853-854.

2007

Vaudaux C, Kaser-Hotz B, Schneider U. Potential for intensity modulated radiation therapy to permit dose escalation for canine nasal cancer. Veterinary Radiology & Ultrasound 2007, 48(5): 475–481.

Ganter M, Schneider U, Heinzelmann M, Zaugg M, Lucchinetti E, Zollinger A, Hofer C. How often should we perform an arterial blood gas analysis during thoracoscopic surgery? Journal of Clinical Anesthesia 2007, 19: 569–575.

Schneider U, Lomax A, Besserer J, Pemler P, Lombriser N, Kaser-Hotz B. The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 2007, 68(3): 892-897.

Durante M, Kraft G, O’Neill P, Reitz G, Sabatier L, Schneider U. Preparatory study of a ground-based space radiobiology program in Europe. Advances in Space Research 2007, 39: 1082-1086.

Crescenti R, Scheib S, Schneider U, Gianolini S. Introducing gel dosimetry in a clinical environment: Customization of polymer gel composition and magnetic resonance imaging parameters used for 3D dose verifications in radiosurgery and intensity modulated radiotherapy. Med Phys 2007, 34(4):1286-1297.

2006

Pemler P, Besserer J, Schneider U, Neuenschwander H. Evaluation of a commercial electron treatment planning system based on Monte Carlo techniques (eMC). Z. Med. Phys. 2006; 16:313–329.

Schneider U, Lomax A, Pemler P, Besserer J, Ross D, Lombriser N, Kaser-Hotz B. The Impact of IMRT and Proton Radiotherapy on Secondary Cancer Incidence. Strahlenther Onkol 2006;182:647–52.

Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol. 2006, 80(2):263-267.

Schneider U, Lomax A, Hauser B, Kaser-Hotz B. Is the risk for secondary cancers after proton therapy enhanced distal to the Planning Target Volume? A two-case report with possible explanations. Radiat Environ Biophys 2006, 45:39-43.

2005

Schneider U, Kaser-Hotz B. Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose-response relationships. Radiat Environ Biophys 2005 Dec 44(3):235-2399.

Schneider U, Zwahlen D, Ross D, Kaser-Hotz B. Estimation of radiation induced cancer from 3D-dose distributions: A concept of organ equivalent dose. Int J Radiat Oncol Biol Phys 2005, 61: 1510-1515.

Schneider U, Kaser-Hotz B. A simple dose-response relationship for modeling secondary cancer incidence after radiotherapy. Z Med Phys 2005 158(1): 31-37.

Schneider U, Pemler P, Besserer J, Pedroni E, Lomax A, Kaser-Hotz B. Patient specific optimization of the relation between CT-Hounsfield units and proton stopping power with proton radiography. Med Phys 2005 32(1): 195-199.

Tourovsky A, Lomax AJ, Schneider U, Pedroni E. Monte Carlo dose calculations for spot scanned proton therapy. Phys Med Biol 2005 50(5): 971-81.

2004

Schneider U, Fiechtner A, Besserer J, Lomax A. Neutron dose from prostheses material during radiotherapy with protons and photons. Phys Med Biol 2004 49: 119–124.

Schneider U, Dellert M, Pedroni E, Pemler P, Besserer J, Moosburger M, Kaser-Hotz B. First proton radiography of an animal patient. Med Phys 2004 31(5): 1046-1051.

Weber D, Rutz H-P, Lomax A, Schneider U, Lombriser N, Zenhauser R, Goitein G. First spinal axis segment irradiation with spot-scanning proton beam delivered in the treatment of a lumbar prinitive neuroectodermal tumour: case report and review of the literature. Clinical Oncology 2004 16: 326-331.